28Sep
28Sep
Women to Watch: Robin Mcbride (Mcbride Sisters Wine Company) and Marian Leitner-Waldman (Archer Roose Wines) Join Roster for Women in Craft Forum During SommCon
SommCon®, the preeminent gathering for wine, beer, and spirits professionals has partnered with Women In Craft Forum to bring forward conversations about the past challenges and future opportunities for women in the craft beverage industry. Held during the SommCon Conference & Beverage Expo, October 5-7 in San Diego, California. The incredible line up of diverse voices joining this year’s roster include trailblazers Robin McBride, co-founder of McBride Sisters Wine Company, and Marian Leitner-Waldman, founder of Archer Roose Wines. These visionary...
26Sep
DeepLook Medical: Medical Imaging Company Raises Series A
DeepLook Medical – a healthtech company specializing in visual enhancement technology for advanced medical imaging – announced it marked the 11th investment in Xcellerant VC Fund 1. Michael Shufeldt, MBA, Principal at Xcellerant Ventures, will join the board. DeepLook Medical’s flagship product, DL Precise, is an innovative AI-powered software that equips healthcare professionals with the tools to detect and assess suspicious lesions in dense breast tissue accurately. Read more >>
26Sep
CytoAgents Receives Third Grant From National Institutes of Health to Advance Research on Cytokine Release Syndrome
CytoAgents Inc., a clinical-stage biotechnology company, dedicated to developing a safe and effective treatment for Cytokine Release Syndrome (CRS), announced today that it has been awarded a $2 million National Institutes of Health (NIH) grant, the third NIH grant in four years. This funding will accelerate the development of its lead drug candidate, CTO1681, an investigational new drug that uses a novel approach designed to prevent and mitigate Cytokine Release Syndrome in patients receiving CAR T-Cell therapy. This is an...
26Sep
Pixability and Ad Fontes Media Join Forces to Empower Advertisers to Safely Support News Content on YouTube
Pixability, (www.pixability.com), a leader in AI-driven contextual targeting, brand suitability and performance on YouTube and CTV, today announced the launch of a brand safety solution for news content with Ad Fontes, a leader in rating news sources for bias and reliability. The new offering will be the only misinformation solution in the marketplace that tackles the two-part problem of protecting advertisers on news channels on YouTube–(1) identifying sources of news that are reputable, trustworthy and not overly biased and (2)...
25Sep
BrandVerge and gimmefy.ai Forge Strategic Partnership
BrandVerge, a premier advertising agency renowned for its data-driven and audience-centric campaigns, today announced a groundbreaking partnership with gimmefy.ai, the world's first customised AI marketing platform. This collaboration aims to redefine the landscape of media planning & buying by seamlessly integrating advanced AI capabilities into BrandVerge's comprehensive suite of services including all aspects of paid media strategy and activation. The partnership between BrandVerge and gimmefy.ai represents a significant leap forward in the advertising industry, combining human expertise with cutting-edge artificial...
24Sep
Wasabi Technologies Powers Johnson Controls with Unmatched Cloud Storage for Mission Critical Video Management
Wasabi Technologies, the hot cloud storage company, today announced it is partnering with Johnson Controls, which offers the world's largest portfolio of building technology, software and services, to deliver high-performance, secure, and cost-effective cloud storage for the video surveillance industry. The combination of Wasabi hot cloud storage and Johnson Controls’ exacqVision Video Management System (VMS) brings organizations an affordable, fully integrated cloud storage and VMS solution with the added security of Wasabi’s immutable buckets to help prevent data loss. "Wasabi...
24Sep
Immusoft to Announce Positive Phase 1 Data for First Engineered B Cell Therapy in a Clinical Trial
Immusoft of CA, a wholly owned subsidiary of Immusoft Corporation (""Immusoft""), a cell therapy company dedicated to improving the lives of patients with rare diseases, today announced positive results from the Phase 1 ISP-001 trial evaluating the therapy in a patient with mucopolysaccharidosis type I (MPS I). The clinical trial is supported by an $8 million award from the California Institute for Regenerative Medicine (CIRM), one of the world's largest institutes dedicated to regenerative medicine. ""Although the Phase 1 focus...
21Sep
University of Arizona Professor Recognized for VR Sight-Enhancing Tech
A longtime University of Arizona optics professor has been honored along with other scientists who used federal funding to invent life-changing technology — in Hong Hua’s case, helping the nearly blind to see clearly. Hua, director of the UA’s 3D Visualization and Imaging Systems laboratory, was featured in the Bayh-Dole Coalition’s 2024 “Faces of American Innovation” report for her invention of an optical device that uses virtual- and augmented-reality technology to allow those with significant vision loss to see with...
19Sep